• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类淋巴细胞中 IKZF1 原干细胞和恶性肿瘤程序的白血病改变。

Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes.

机构信息

Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology and Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200025, China.

Biodynamic Optical Imaging Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.

出版信息

Cell Death Dis. 2018 May 1;9(5):526. doi: 10.1038/s41419-018-0600-3.

DOI:10.1038/s41419-018-0600-3
PMID:29743561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5943605/
Abstract

Somatic cells acquire stem cell-like properties during cancerous transformation; however, mechanisms through which committed cells develop stemness and malignancy remain largely unknown. Here we uncovered upregulated stem cell program in leukaemic lymphoblasts of patients with IKZF1 alterations by analysing the archived gene-expression profiling datasets. We then used a frequent IKZF1 deletion, IK6, as a model via transduction into human primitive haematopoietic cells, followed by xenotransplantation in mice. Immunophenotypically defined stem, pro-B, and immature/mature (IM/M)-B cells were collected from primary recipients for functional assay and transcriptome profiling. Successful reconstitution in secondary recipient mice revealed the stemness of IK6 pro-B and IM/M-B cells. Upregulated stemness and malignancy programs in IK6 cells confirmed IK6 effects. Interestingly, these programs corresponded to distinct canonical pathways. Remarkably, the pathway profile mapped in the modelled cells well mirrored that in patients' leukaemic cells; therefore, our study provides a seminal insight into the cancerous reprogramming of somatic cells.

摘要

体细胞在癌变过程中获得类似干细胞的特性;然而, committed cells 发展为干细胞和恶性肿瘤的机制在很大程度上仍然未知。在这里,我们通过分析存档的基因表达谱数据集,发现 IKZF1 改变的白血病淋巴母细胞中上调的干细胞程序。然后,我们使用频繁的 IKZF1 缺失 IK6 通过转导到人类原始造血细胞,然后进行异种移植到小鼠中作为模型。从原发性受者中收集免疫表型定义的干细胞、前 B 细胞和未成熟/成熟 (IM/M)-B 细胞进行功能测定和转录组谱分析。在二级受者小鼠中成功重建揭示了 IK6 前 B 和 IM/M-B 细胞的干细胞特性。IK6 细胞中上调的干细胞和恶性肿瘤程序证实了 IK6 的作用。有趣的是,这些程序对应于不同的经典途径。值得注意的是,模型细胞中的途径图谱很好地反映了患者白血病细胞中的图谱;因此,我们的研究为体细胞的癌变重编程提供了重要的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/789d82103685/41419_2018_600_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/0a48ab5b4c1a/41419_2018_600_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/400bc6296074/41419_2018_600_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/996c4cafe414/41419_2018_600_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/789d82103685/41419_2018_600_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/0a48ab5b4c1a/41419_2018_600_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/400bc6296074/41419_2018_600_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/996c4cafe414/41419_2018_600_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e4/5943605/789d82103685/41419_2018_600_Fig4_HTML.jpg

相似文献

1
Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes.人类淋巴细胞中 IKZF1 原干细胞和恶性肿瘤程序的白血病改变。
Cell Death Dis. 2018 May 1;9(5):526. doi: 10.1038/s41419-018-0600-3.
2
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.一个 IKAROS 的显性负性异构体可扩增原始正常人类造血细胞。
Stem Cell Reports. 2014 Nov 11;3(5):841-57. doi: 10.1016/j.stemcr.2014.09.006. Epub 2014 Oct 11.
3
The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells.伊卡洛斯剪接异构体伊卡洛斯6可使小鼠造血祖细胞永生化。
Int J Cancer. 2008 Sep 15;123(6):1240-5. doi: 10.1002/ijc.23706.
4
Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.显性负性Ikaros 6的阶段特异性过表达揭示了Ikaros在人类B细胞分化过程中的不同作用。
Mol Immunol. 2009 May;46(8-9):1736-43. doi: 10.1016/j.molimm.2009.02.004. Epub 2009 Mar 13.
5
Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.显性负性IKAROS增强野生型小鼠BA/F3细胞中白细胞介素-3刺激的信号传导,但对BCR-ABL1(+)小鼠BA/F3细胞无效。
Exp Hematol. 2015 Jul;43(7):514-23.e1-2. doi: 10.1016/j.exphem.2015.04.004. Epub 2015 May 4.
6
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.肿瘤抑制因子BTG1和IKZF1在小鼠白血病发展过程中协同作用,并增加B细胞前体急性淋巴细胞白血病患者的复发风险。
Haematologica. 2017 Mar;102(3):541-551. doi: 10.3324/haematol.2016.153023. Epub 2016 Dec 15.
7
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.流式细胞术检测伊卡罗斯(IKZF1)改变和第 15 天微小残留病可预测儿童 BCR/ABL 阴性急性淋巴细胞白血病的预后。
Pediatr Blood Cancer. 2013 Mar;60(3):420-7. doi: 10.1002/pbc.24299. Epub 2012 Sep 19.
8
SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.SOCS2 在应激条件下控制造血细胞的增殖和干性,其失调标志着不良的急性白血病。
Cancer Res. 2015 Jun 1;75(11):2387-99. doi: 10.1158/0008-5472.CAN-14-3625. Epub 2015 Apr 9.
9
[Expression and clinical significance of IKZF1 gene IK6 isoform in adult acute lymphoblastic leukemia].IKZF1基因IK6亚型在成人急性淋巴细胞白血病中的表达及临床意义
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):539-43. doi: 10.7534/j.issn.1009-2137.2013.03.001.
10
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.转录因子 Ikaros 在骨髓增殖性肿瘤中的缺失。
Leukemia. 2010 Jul;24(7):1290-8. doi: 10.1038/leu.2010.99. Epub 2010 May 27.

引用本文的文献

1
Fetal hepatocytes protect the HSPC genome via fetuin-A.胎儿肝细胞通过胎球蛋白-A保护造血干细胞基因组。
Nature. 2025 Jan;637(8045):402-411. doi: 10.1038/s41586-024-08307-x. Epub 2024 Dec 4.
2
gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia.基因缺失导致B细胞前体急性淋巴细胞白血病对阿糖胞苷产生耐药性。
Haematologica. 2024 Dec 1;109(12):3904-3917. doi: 10.3324/haematol.2023.284357.
3
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care.

本文引用的文献

1
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.急性淋巴细胞白血病中DUX4和ERG的失调
Nat Genet. 2016 Dec;48(12):1481-1489. doi: 10.1038/ng.3691. Epub 2016 Oct 24.
2
Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.维甲酸在IKZF1突变的BCR-ABL1急性淋巴细胞白血病中的疗效
Cancer Cell. 2015 Sep 14;28(3):343-56. doi: 10.1016/j.ccell.2015.07.016. Epub 2015 Aug 27.
3
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
癌症干细胞理论:表观基因组与基因组生物标志物在癌症治疗中的临床意义
Cancers (Basel). 2023 Nov 22;15(23):5533. doi: 10.3390/cancers15235533.
4
Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia.非布司他与别嘌醇治疗3至5期慢性肾脏病合并高尿酸血症患者的比较
Emerg Med Int. 2022 Oct 11;2022:1177946. doi: 10.1155/2022/1177946. eCollection 2022.
5
Ikaros Proteins in Tumor: Current Perspectives and New Developments.肿瘤中的Ikaros蛋白:当前观点与新进展
Front Mol Biosci. 2021 Dec 7;8:788440. doi: 10.3389/fmolb.2021.788440. eCollection 2021.
6
Prognostic Impact of Somatic Copy Number Alterations in Childhood B-Lineage Acute Lymphoblastic Leukemia.儿童 B 系急性淋巴细胞白血病中体细胞拷贝数改变的预后影响。
Curr Oncol Rep. 2020 Nov 14;23(1):2. doi: 10.1007/s11912-020-00998-5.
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
4
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.使用DESeq2对RNA测序数据的倍数变化和离散度进行适度估计。
Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
5
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.一个 IKAROS 的显性负性异构体可扩增原始正常人类造血细胞。
Stem Cell Reports. 2014 Nov 11;3(5):841-57. doi: 10.1016/j.stemcr.2014.09.006. Epub 2014 Oct 11.
6
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Ph 样急性淋巴细胞白血病中可靶向的激酶激活病变。
N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088.
7
Leukemia propagating cells rebuild an evolving niche in response to therapy.白血病增殖细胞对治疗产生反应,重新构建不断演变的龛位。
Cancer Cell. 2014 Jun 16;25(6):778-93. doi: 10.1016/j.ccr.2014.04.015.
8
Stem cell programs are retained in human leukemic lymphoblasts.干细胞程序保留在人类白血病淋巴母细胞中。
Oncogene. 2015 Apr 16;34(16):2083-93. doi: 10.1038/onc.2014.148. Epub 2014 Jun 9.
9
Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.显性负性 Ikaros 与 BCR-ABL1 协同诱导异种移植中的人急性髓系白血病。
Leukemia. 2015 Jan;29(1):177-87. doi: 10.1038/leu.2014.150. Epub 2014 May 5.
10
Stage-specific control of early B cell development by the transcription factor Ikaros.转录因子 Ikaros 对早期 B 细胞发育的阶段特异性控制。
Nat Immunol. 2014 Mar;15(3):283-93. doi: 10.1038/ni.2828. Epub 2014 Feb 9.